GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

Endexx EDXC · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

+9900.00%

Close of 6 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2022

Revenue

$2.1m

FY2018FY2022

Net income

−$4.9m

FY2018FY2022

Free cash flow

−$2.1m

FY2018FY2022

Shareholders' equity

−$9.4m

FY2018FY2022

Income statement

Fiscal years

FY2022FY2021FY2020FY2019FY2018
Revenue$2.1m$650,500$1.1m$1.1m$745,000
Research and development$27,100$10,200$15,300$18,700$43,600
Operating income−$3.7m−$5.4m−$3.7m−$3.7m−$1.0m
Net income−$4.9m−$6.8m−$9.2m−$8.3m−$2.5m
Diluted earnings per share-0.01-0.02-0.02-0.02-0.01

Balance sheet

At each fiscal year end

FY2022FY2021FY2020FY2019FY2018
Total assets$13.3m$1.8m$1.9m$1.8m$345,200
Cash and short-term investments$656,800$20,900$4,600$36,400$155,300
Total liabilities$22.7m$11.7m$13.6m$7.7m$2.9m
Debt$10.0m$6.9m$4.9m$2.6m$1.3m
Shareholders' equity−$9.4m−$10.0m−$11.7m−$5.9m−$2.6m
Shares outstanding504m455m379m343m289m

Cash flow

Fiscal years

FY2022FY2021FY2020FY2019FY2018
Cash from operations−$2.1m−$3.7m−$2.5m−$3.2m−$1.0m
Capital spending——−$100,000−$73,300−$2,500
Free cash flow−$2.1m−$3.7m−$2.6m−$3.2m−$1.0m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue24.4%——
Operating income-0.4%——
Net income-16.1%——

Valuation history

At each fiscal year end

FY2022FY2021FY2020
Price to earnings-0.4-0.2-0.4
Price to sales0.91.82.9

Share price return

Finished calendar years

202520242023202220212020
Return-87%-47%-67%24%-64%41%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.